Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  11/26/2002
 
Trade Name:  Strattera
 
Generic Name or Proper Name (*):  atomoxetine
 
Indications Studied:  Attention-Deficit Hyperactivity Disorder
 
Label Changes Summary:  Safety and effectiveness established down to 6 years of age It is unknown whether final adult height or weight is affected by treatment. Patients on long-term treatment should be monitored The effectiveness of atomoxetine beyond 9 weeks and safety beyond 1 year in pediatric patients, has not been systematically evaluated in controlled trials
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Lilly
 
Pediatric Exclusivity Granted Date:  12/18/2001
 
NNPS:  FALSE'
 
Therapeutic Category:  Non-stimulant ADHD treatment
 
-
-